Related Experiment Video
Updated: Apr 14, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study
Ruth Ann Marrie1, Bo N Yu1, Stella Leung1
1University of Manitoba, Health Sciences Centre, GF 533, 820 Sherbrook Street, Winnipeg, MB, Canada R3A 1R9.
Background:
Studies suggest an altered risk of ischemic heart disease (IHD) in multiple sclerosis (MS), but data are limited. We aimed to validate and apply administrative case definitions to estimate the incidence and prevalence of IHD in MS.
Methods:
Using administrative data we identified persons with incident MS (MSPOP) and a matched general population (GPOP) cohort. We developed case definitions for IHD using ICD-9/10 codes and prescription claims, compared them to medical records, then applied them to evaluate the incidence and prevalence of IHD.
Results:
Agreement between medical records and the administrative definition using ≥1 hospital or ≥2 physician claims over 5 years was moderate (kappa=0.66; 95% CI: 0.42-0.90). In 2005, the age-standardized prevalence of IHD was 6.77% (95% CI: 5.48-8.07%) in the MSPOP and 6.11% (95% CI: 5.56-6.66%) in the GPOP. The prevalence of IHD was higher in the MSPOP than the GPOP among persons aged 20-44 years (prevalence ratio 1.87; 95% CI: 1.65-2.12) and aged 45-59 years (prevalence ratio 1.21; 95% CI: 1.08-1.35). The incidence of IHD was also higher in the MSPOP (incidence rate ratio 1.24; 95% CI: 0.97-1.59).
Conclusions:
More than 5% of the MSPOP has IHD. The incidence of IHD was higher than expected in persons aged <60 years. Further evaluation of this issue is warranted.
Insights
Multiple sclerosis (MS) patients have a higher incidence of ischemic heart disease (IHD) before age 60. This study validated administrative definitions to assess IHD prevalence and incidence in MS populations.
Area of Science:
- Cardiovascular Epidemiology
- Neurology
- Health Services Research
Background:
- Limited data exist on ischemic heart disease (IHD) risk in multiple sclerosis (MS).
- Administrative case definitions for IHD in MS require validation for accurate incidence and prevalence estimation.
Purpose of the Study:
- To validate administrative case definitions for IHD.
- To estimate the incidence and prevalence of IHD in a multiple sclerosis population using validated definitions.
Main Methods:
- Utilized administrative data to identify multiple sclerosis (MSPOP) and matched general population (GPOP) cohorts.
- Developed and validated IHD case definitions using ICD-9/10 codes and prescription claims against medical records.
- Applied validated definitions to estimate IHD prevalence and incidence in MS and GPOP cohorts.
Main Results:
- Moderate agreement (kappa=0.66) was found between administrative definitions and medical records for IHD.
- In 2005, IHD prevalence was 6.77% in MSPOP vs. 6.11% in GPOP.
- IHD prevalence and incidence were higher in MSPOP compared to GPOP, particularly in individuals under 60 years old.
Conclusions:
- Over 5% of the multiple sclerosis population studied has ischemic heart disease.
- The incidence of IHD is elevated in individuals with MS younger than 60 years.
- Further research is necessary to understand and address the increased IHD risk in the MS population.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...

